(Q50778822)

19 March 2018

title

One third of patients with radiotherapy-induced nausea consider their antiemetic treatment insufficient. (English)

1 reference

19 March 2018

adaptive radiation therapy

main subject

0 references

author

Gunnar Steineck

3

1 reference

19 March 2018

author name string

Anna Enblom

1

1 reference

19 March 2018

Beata Bergius Axelsson

2

1 reference

19 March 2018

Mats Hammar

4

1 reference

19 March 2018

Sussanne Börjeson

5

1 reference

19 March 2018

publication date

5 June 2008

1 reference

19 March 2018

Supportive Care in Cancer

published in

1 reference

19 March 2018

volume

17

1 reference

19 March 2018

issue

1

1 reference

19 March 2018

page(s)

23-32

1 reference

19 March 2018

https://scigraph.springernature.com/pub.10.1007/s00520-008-0445-x

exact match

0 references

cites work

Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-008-0445-X

On the receiving end. V: Patient perceptions of the side effects of cancer chemotherapy in 1993.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-008-0445-X

Activities of daily living instruments:optimizing scales for neurologic assessments

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00520-008-0445-X

Treatment implications for radiation-induced nausea and vomiting in specific patient groups

21 January 2018

1 reference

12 December 2020

A one-item question with a Likert or Visual Analog Scale adequately measured current anxiety.

1 reference

12 December 2020

Management of radiation-induced nausea and vomiting

1 reference

12 December 2020

Measuring chemotherapy-induced nausea and emesis.

1 reference

12 December 2020

Prophylactic tropisetron versus rescue tropisetron in fractionated radiotherapy to moderate or high emetogenic areas: a prospective randomized open label study in cancer patients

1 reference

12 December 2020

Closing the gap in prophylactic antiemetic therapy: patient factors in calculating the emetogenic potential of chemotherapy

1 reference

12 December 2020

Double-blind, randomized, parallel-group study on the efficacy and safety of oral granisetron and oral ondansetron in the prophylaxis of nausea and vomiting in patients receiving hyperfractionated total body irradiation

1 reference

12 December 2020

Prevention of radiotherapy-induced emesis

1 reference

12 December 2020

Nausea: the neglected symptom?

1 reference

12 December 2020

The efficacy and safety of once-daily Kytril (granisetron hydrochloride) tablets in the prophylaxis of nausea and emesis following fractionated upper abdominal radiotherapy

1 reference

12 December 2020

Assessment of postoperative nausea using a visual analogue scale.

1 reference

12 December 2020

Quality of life consequences of chemotherapy-induced emesis

1 reference

12 December 2020

Recommendations for the use of antiemetics: evidence-based, clinical practice guidelines. American Society of Clinical Oncology

1 reference

12 December 2020

Aetiology and prevention of emesis induced by radiotherapy

1 reference

12 December 2020

[Individually risk-adapted antiemetic step therapy]

1 reference

12 December 2020

Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology

1 reference

12 December 2020

Chemotherapy-induced nausea and vomiting: the importance of acute antiemetic control

1 reference

12 December 2020

Clinical relevance of single item quality of life indicators in cancer clinical trials

1 reference

12 December 2020

American Society of Clinical Oncology guideline for antiemetics in oncology: update 2006.

1 reference

12 December 2020

The clinical significance of quality of life assessments in oncology: a summary for clinicians

1 reference

12 December 2020

Assessment of the quality of life of patients with advanced cancer

1 reference

12 December 2020

Radiation-induced emesis: a prospective observational multicenter Italian trial. The Italian Group for Antiemetic Research in Radiotherapy

1 reference

12 December 2020

Prevention of radiotherapy-induced emesis

1 reference

12 December 2020

Radiotherapy-induced nausea and vomiting (RINV): antiemetic guidelines

1 reference

12 December 2020

Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial.

1 reference

12 December 2020

Symptom documentation in cancer survivors as a basis for therapy modifications.

1 reference

12 December 2020

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life.

1 reference

12 December 2020

5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis: can we safely reduce the dose of administered agents?

1 reference

12 December 2020

5-hydroxytryptamine-3 receptor antagonist with or without short-course dexamethasone in the prophylaxis of radiation induced emesis: a placebo-controlled randomized trial of the National Cancer Institute of Canada Clinical Trials Group (SC19).

1 reference

12 December 2020

A hierarchical step-model for causation of bias-evaluating cancer treatment with epidemiological methods

1 reference

12 December 2020

1 reference

12 December 2020

Vaginal changes and sexuality in women with a history of cervical cancer

1 reference

12 December 2020

Ondansetron versus a chlorpromazine and dexamethasone combination for the prevention of nausea and vomiting: a prospective, randomised study to assess efficacy, cost effectiveness and quality of life following single-fraction radiotherapy.

1 reference

12 December 2020

Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting

1 reference

12 December 2020

Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group.

1 reference

12 December 2020

Nausea and vomiting remain a significant clinical problem: trends over time in controlling chemotherapy-induced nausea and vomiting in 1413 patients treated in community clinical practices

1 reference

12 December 2020

Measuring anxiety and depression in the oncology setting using visual-digital scales

1 reference

12 December 2020

Functional relevance of antiemetic control. Experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant.

1 reference

12 December 2020

Quality-of-life assessment in oncology. Achievements and challenges

1 reference

12 December 2020

Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall

1 reference

12 December 2020

Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?

1 reference

12 December 2020

Patient statement of satisfaction with antiemetic treatment is related to quality of life.

1 reference

12 December 2020

Dexamethasone for the prophylaxis of radiation-induced emesis: a National Cancer Institute of Canada Clinical Trials Group phase III study.

1 reference

12 December 2020

Prevention of chemotherapy- and radiotherapy-induced emesis: results of Perugia Consensus Conference. Antiemetic Subcommittee of the Multinational Association of Supportive Care in Cancer (MASCC)

1 reference

12 December 2020

Results of a randomized, double-blind comparative study of ondansetron and metoclopramide in the prevention of nausea and vomiting following high-dose upper abdominal irradiation

1 reference

12 December 2020

Evidence-based recommendations for the use of antiemetics in radiotherapy.

1 reference

12 December 2020

Treatment of nausea and emesis during cancer chemotherapy. Discrepancies between antiemetic effect and well-being

1 reference

12 December 2020

10.1007/S00520-008-0445-X

Identifiers

DOI

1 reference

19 March 2018

1 reference

19 March 2018